| RS121913384 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS121913385 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS121913386 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS121913387 |
CDKN2A
|
Health Risk |
Pathogenic |
Neoplasm, Familial melanoma |
| RS121913388 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Melanoma, cutaneous malignant |
| RS121913389 |
CDKN2A
|
Health Risk |
Pathogenic |
Lip and oral cavity carcinoma, Hereditary cancer-predisposing syndrome |
| RS121913396 |
CTNNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Pilomatrixoma, Sertoli-Leydig cell tumor |
| RS121913399 |
CTNNB1
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Adamantinous craniopharyngioma |
| RS121913400 |
CTNNB1
|
Health Risk |
Pathogenic; other |
Carcinoma of colon, Pilomatrixoma |
| RS121913403 |
CTNNB1
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Pilomatrixoma |
| RS121913407 |
CTNNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatocellular carcinoma, Neoplasm |
| RS121913409 |
CTNNB1
|
Health Risk |
Pathogenic; other |
Hepatocellular carcinoma, Nephroblastoma |
| RS121913412 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Desmoid tumor caused by somatic mutation, Hepatoblastoma |
| RS121913413 |
CTNNB1
|
Health Risk |
Likely pathogenic |
Pilomatrixoma, Desmoid disease |
| RS121913421 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosine kinase inhibitor response, EGFR-related lung cancer |
| RS121913428 |
EGFR
|
Health Risk |
Pathogenic |
Non-small cell lung carcinoma, Neoplasm |
| RS121913449 |
ABL1
|
Health Risk |
Pathogenic |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS121913454 |
ABL1
|
Health Risk |
Pathogenic |
Lip and oral cavity carcinoma, Lip and oral cavity carcinoma |
| RS121913456 |
ABL1
|
Health Risk |
Pathogenic |
— |
| RS121913457 |
ABL1
|
Health Risk |
Pathogenic |
Chronic myelogenous leukemia, BCR-ABL1 positive |
| RS121913459 |
ABL1
|
Health Risk |
Likely pathogenic; association |
Leukemia, Philadelphia chromosome-positive |
| RS121913461 |
ABL1
|
Health Risk |
Pathogenic |
Leukemia, Philadelphia chromosome-positive |
| RS121913462 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS121913465 |
EGFR
|
Health Risk |
Pathogenic |
Non-small cell lung carcinoma, Neoplasm |
| RS121913469 |
ERBB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lung adenocarcinoma, Lung adenocarcinoma |
| RS121913474 |
FGFR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Beare-Stevenson cutis gyrata syndrome, Adenoid cystic carcinoma |
| RS121913477 |
FGFR2
|
Health Risk |
Pathogenic |
Beare-Stevenson cutis gyrata syndrome, FGFR2-related craniosynostosis |
| RS121913478 |
FGFR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Beare-Stevenson cutis gyrata syndrome, Endometrial carcinoma |
| RS121913479 |
FGFR3
|
Health Risk |
Pathogenic |
Thanatophoric dysplasia type 1, Epidermal nevus |
| RS121913480 |
FGFR3
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS121913482 |
FGFR3
|
Health Risk |
Pathogenic |
Thanatophoric dysplasia type 1, Skeletal dysplasia with acanthosis nigricans |
| RS121913483 |
FGFR3
|
Health Risk |
Pathogenic |
Seborrheic keratosis, Thanatophoric dysplasia type 1 |
| RS121913484 |
FGFR3
|
Health Risk |
Pathogenic |
Thanatophoric dysplasia type 1, Thanatophoric dysplasia type 1 |
| RS121913485 |
FGFR3
|
Health Risk |
Pathogenic |
Thanatophoric dysplasia type 1, See cases |
| RS121913486 |
FLT3
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS121913487 |
FLT3
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS121913488 |
FLT3
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS121913491 |
FLT3
|
Health Risk |
Likely pathogenic |
Acute myeloid leukemia, Acute myeloid leukemia |
| RS121913492 |
GNAQ
|
Health Risk |
Pathogenic |
Sturge-Weber syndrome, Abnormal cardiovascular system morphology |
| RS121913494 |
GNAS
|
Health Risk |
Pathogenic |
Pituitary adenoma 3, multiple types |
| RS121913495 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
McCune-Albright syndrome, Sex cord-stromal tumor |
| RS121913496 |
HRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 3, Noonan syndrome 3 |
| RS121913499 |
IDH1
|
Health Risk |
Pathogenic |
Acute myeloid leukemia, Enchondromatosis |
| RS121913500 |
IDH1
|
Health Risk |
Pathogenic |
Glioblastoma multiforme, somatic |
| RS121913502 |
IDH2
|
Health Risk |
Pathogenic/Likely pathogenic |
D-2-hydroxyglutaric aciduria 2, Neoplasm |
| RS121913503 |
IDH2
|
Health Risk |
risk factor |
Acute myocardial infarction, Acute myocardial infarction |
| RS121913505 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS121913506 |
KIT
|
Health Risk |
Pathogenic |
Germ cell tumor of testis, Dysgerminoma |
| RS121913507 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dysgerminoma, Gastrointestinal stromal tumor |
| RS121913509 |
KIT
|
Health Risk |
Pathogenic |
Mastocytosis, Mastocytosis |
| RS121913512 |
KIT
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, familial |
| RS121913513 |
KIT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS121913514 |
KIT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Gastrointestinal stromal tumor |
| RS121913517 |
KIT
|
Health Risk |
Pathogenic/Likely pathogenic |
Gastrointestinal stromal tumor, Germinoma |
| RS121913521 |
KIT
|
Health Risk |
Likely pathogenic |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS121913527 |
KRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
RASopathy, OCULOECTODERMAL SYNDROME |
| RS121913528 |
KRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Bladder cancer, transitional cell |
| RS121913529 |
KRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Carcinoma of pancreas, Epidermal nevus |
| RS121913530 |
KRAS
|
Health Risk |
Pathogenic |
Lung carcinoma, Non-small cell lung carcinoma |
| RS121913535 |
KRAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pilocytic astrocytoma, Non-small cell lung carcinoma |
| RS121913538 |
KRAS
|
Health Risk |
Likely pathogenic |
OCULOECTODERMAL SYNDROME, SOMATIC |
| RS121913547 |
LYZ
|
Health Risk |
Pathogenic |
Amyloidosis, hereditary systemic 5 |
| RS121913549 |
LYZ
|
Health Risk |
Pathogenic |
Amyloidosis, hereditary systemic 5 |
| RS121913550 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS121913551 |
PLOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS121913552 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS121913553 |
PLOD1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS121913554 |
PLOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS121913555 |
LIM2
|
Health Risk |
Pathogenic |
Cataract 19 multiple types, Cataract 19 multiple types |
| RS121913556 |
MC3R
|
Health Risk |
risk factor |
OBESITY (BMIQ9), SUSCEPTIBILITY TO |
| RS121913558 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS121913559 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, MC4R-related disorder |
| RS121913560 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, MC4R-related disorder |
| RS121913561 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Obesity |
| RS121913562 |
MC4R
|
Health Risk |
Pathogenic |
Obesity, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS121913563 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
Obesity, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS121913564 |
MC4R
|
Health Risk |
Pathogenic/Likely pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Obesity |
| RS121913565 |
MC4R
|
Health Risk |
Pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 |
| RS121913566 |
MC4R
|
Health Risk |
Likely pathogenic |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, Obesity due to melanocortin 4 receptor deficiency |
| RS121913567 |
MC4R
|
Health Risk |
Conflicting classifications of pathogenicity |
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20, MC4R-related disorder |
| RS121913568 |
ACAN
|
Health Risk |
Likely pathogenic |
Spondyloepimetaphyseal dysplasia, aggrecan type |
| RS121913569 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS121913570 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS121913571 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS121913572 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS121913573 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS121913574 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital muscular dystrophy due to partial LAMA2 deficiency, LAMA2-related muscular dystrophy |
| RS121913575 |
LAMA2
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to partial LAMA2 deficiency, Merosin deficient congenital muscular dystrophy |
| RS121913576 |
LAMA2
|
Health Risk |
Pathogenic |
Congenital muscular dystrophy due to partial LAMA2 deficiency, Merosin deficient congenital muscular dystrophy |
| RS121913577 |
LAMA2
|
Health Risk |
Pathogenic |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS121913578 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Profound intellectual disability |
| RS121913579 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS121913580 |
MTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcobalamin deficiency type cblG, Neural tube defects |
| RS121913581 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS121913582 |
MTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylcobalamin deficiency type cblG, Neural tube defects |
| RS121913583 |
MPZ
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913584 |
MPZ
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |
| RS121913585 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT |
| RS121913586 |
MPZ
|
Health Risk |
Pathogenic |
DEJERINE-SOTTAS SYNDROME, AUTOSOMAL DOMINANT |
| RS121913587 |
MPZ
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 1B, Charcot-Marie-Tooth disease |